Induction of nitric oxide synthase during Japanese encephalitis virus infection: evidence of protective role.
The ability of Japanese encephalitis virus (JEV) and JEV-induced macrophage-derived factor (MDF) to modulate nitric oxide synthase (NOS) activity in brain and tumor necrosis factor-alpha (TNF-alpha) and the possible antiviral role of NOS during JEV infection were investigated. NOS activity and particularly that of the inducible form of NOS (iNOS) was significantly enhanced in JEV or JEV-induced MDF-treated mice. Following JEV infection, total NOS activity in brain was gradually increased from Day 3 and reached a peak on Day 6. MDF-induced NOS activity and iNOS activity were dose dependent and maximum activity was observed at 1 h after treatment. The response was sensitive to anti-MDF antibody treatment and N(G)-monomethyl-L-arginine (L-NMMA), an inhibitor of NOS. Pretreatment of JEV-infected mice with L-NMMA increased the mortality as evident from reduced mean survival time (MST, 11.8 days) compared to placebo treated JEV-infected mice (MST, 17 days). The enhanced level of TNF-alpha observed in the early phase of JEV infection correlated well with the enhanced activity of iNOS. These observations thus provide evidence of the protective role of iNOS during JEV infection and indicate that iNOS may be a key mediator in host innate immune response to infection.
Saxena
S K
SK
Postgraduate Department of Microbiology, King George's Medical College, Lucknow 226003, India.
Mathur
A
A
Srivastava
R C
RC
D000818:Animals; D001921:Brain / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism / Q000821:virology; D004195:Disease Models, Animal; D004664:Encephalitis Virus, Japanese / Q000187:drug effects / Q000502:physiology; D004672:Encephalitis, Japanese / Q000201:enzymology* / Q000378:metabolism / Q000401:mortality; D004791:Enzyme Inhibitors / Q000494:pharmacology; D015151:Immunoblotting; D016215:Macrophage-Activating Factors / Q000494:pharmacology*; D051379:Mice; D009026:Mortality; D019001:Nitric Oxide Synthase / Q000096:biosynthesis* / Q000502:physiology; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism; D014779:Virus Replication / Q000187:drug effects; D019323:omega-N-Methylarginine / Q000494:pharmacology
D004791:Enzyme Inhibitors; D016215:Macrophage-Activating Factors; D014409:Tumor Necrosis Factor-alpha; D019323:omega-N-Methylarginine; D019001:Nitric Oxide Synthase